Your browser doesn't support javascript.
loading
Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML.
Drula, Rares; Iluta, Sabina; Gulei, Diana; Iuga, Cristina; Dima, Delia; Ghiaur, Gabriel; Buzoianu, Anca Dana; Ciechanover, Aaron; Tomuleasa, Ciprian.
Afiliação
  • Drula R; Research Center for Advanced Medicine - MedFUTURE, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Iluta S; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania.
  • Gulei D; Research Center for Advanced Medicine - MedFUTURE, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Iuga C; Research Center for Advanced Medicine - MedFUTURE, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania; Department of Pharmaceutical Analysis, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Dima D; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania.
  • Ghiaur G; Department of Oncology, The Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
  • Buzoianu AD; Department of Pharmacology, Toxicology and Clinical Pharmacology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Ciechanover A; Research Center for Advanced Medicine - MedFUTURE, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania; Rappaport Technion Integrated Cancer Center, Technion-Israel Institute of
  • Tomuleasa C; Research Center for Advanced Medicine - MedFUTURE, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napo
Blood Rev ; 56: 100971, 2022 11.
Article em En | MEDLINE | ID: mdl-35595613
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Mieloma Múltiplo / Transtornos Mieloproliferativos Limite: Humans Idioma: En Revista: Blood Rev Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Romênia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Mieloma Múltiplo / Transtornos Mieloproliferativos Limite: Humans Idioma: En Revista: Blood Rev Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Romênia